Who
Peter Hirth
Director
Company insider
Files Form 4 as: Director, TRex Bio; Director, Aligos Therapeutics; Director, IO Biotech; Director, Vaxcyte.
In numbers
- Trades disclosed
- 22
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 4
- Companies where not an officer
- 4
- First trade
- 2 Jun 2021
- Last trade
- 8 Oct 2026
- Last filed
- 8 Oct 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 8 Oct 2026filed 8 Oct 2026 | TRXB TRex Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,860 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,860 at $0.00 | filing |
| 25 Jun 2025filed 26 Jun 2025 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,860 at $0.00 | filing |
| 5 Jun 2025filed 6 Jun 2025 | IO Biotechoption or derivative | SEC FORM 4 Code A | —35,144 at $0.00 | filing |
| 27 Jun 2024filed 28 Jun 2024 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,250 at $0.00 | filing |
| 6 Jun 2024filed 10 Jun 2024 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —1,550 at $0.00 | filing |
| 6 Jun 2024filed 7 Jun 2024 | IO Biotechoption or derivative | SEC FORM 4 Code A | —45,642 at $0.00 | filing |
| 28 Feb 2024filed 28 Feb 2024 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,411 at $0.00 | filing |
| 27 Feb 2024filed 28 Feb 2024 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 at $0.00 | filing |
| 20 Jul 2023filed 21 Jul 2023 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 13 Jun 2023filed 15 Jun 2023 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —2,500 at $0.00 | filing |
| 8 Jun 2023filed 13 Jun 2023 | IO Biotechoption or derivative | SEC FORM 4 Code A | —41,533 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | ALGS Aligos Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | PCVX Vaxcyteoption or derivative · Biotechnology | SEC FORM 4 Code A | —18,750 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | PCVX VaxcyteBiotechnology | SEC FORM 4 Code A | —3,125 at $0.00 | filing |
| 26 May 2022filed 31 May 2022 | IO Biotechoption or derivative | SEC FORM 4 Code A | —23,885 at $0.00 | filing |
| 4 Nov 2021filed 8 Nov 2021 | IO Biotechoption or derivative | SEC FORM 4 Code A | —34,731 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.